Highlights
About
Programmable Medicine using synthetic DNA molecular machines
TrioxNano's powerhouse created a biosphere of programmed therapeutic/diagnostic solutions based on synthetic DNA molecular machines Our team of exceptional scientists fluent in the secrets of DNA programming & highly skilled execs has led to the development of the Programmed Medicine Biosphere. Granted global all inclusive patents & winning the prestigious H2020 2.7M grant allowed us develop :
P-ADC - Programmable ADCs (Aptamer DNAzyme Conjugates) Technology: Market Challenges: Analog treatments exhibit low efficacy and high toxicity, addressing only 15% of cancer targets. Our Solution: P-ADC replaces analog components with a digital aptamer and programmed DNAzyme, excelling in highly targeted mRNA knockdown. Market Potential: Estimated at $550B, addressing the growing need for precision medicine.
P-DDP - Programmable Drug Delivery Platforms: Market Challanges: Traditional drug delivery lacks precision, leading to low treatment effectiveness and side effects. Our Solution: P-DDP enables precise drug delivery, significantly improving efficacy and reducing side effects. Market Potential: Estimated at $100B, capitalizing on the demand for personalized medicine.
P-DST - Programmable DNA Strip Technology: Market Challanges: Current antigen tests lack sensitivity, specificity, and home-testing capabilities. Our Solution: P-DST revolutionizes antigen testing with a programmable approach, offering at-home testing for thousands of antigens. Market Potential: Annual revenues estimated at $140B, meeting the increasing demand for accurate home diagnostics.
PCPM - Precision Cancer Profiling using mRNA Knockdown Technology: Market Challanges: Current cancer tests lack functional insights, precision, and cost-effectiveness. Our Solution: PCPM provides functional information, cost-effective mRNA profiling, and AI + ML recommendations for a holistic understanding. Market Potential: Exceeding $100B, addressing the rising need for functional cancer diagnostics.
Identity
| Name | TrioxNano |
|---|---|
| Slug | trioxnano |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwMa41IILDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Dec 2024 ceased to operate |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Jerusalem District |
| HQ city | Jerusalem |
| HQ address | Shim'on Rokah Street 8, Jerusalem, Israel |
Web & social
| YouTube | https://www.youtube.com/watch?app=desktop&v=olxxDUz0aks |
|---|
Classifications
Funding
| Total raised | $3.6M |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}